Sanofi deepens cancer drive with two deals worth $1.2 billion, Innate jumps savita12 Jan 2016 9:24 AM ISTParis: Sanofi boosted its presence in cancer research by signing two deals with biotech companies worth up to $1.2 billion, as the French drugmaker...
FDA approves Bridion to reverse effects of neuromuscular blocking drugs savita17 Dec 2015 11:21 AM ISTThe U.S. Food and Drug Administration approved Bridion (sugammadex) injection to reverse the effects of neuromuscular blockade induced by rocuronium...
Biotech startup Kallyope snags $44 mln Series A Pooja12 Dec 2015 9:37 AM ISTNEW YORK, December 10, 2015 – Kallyope Inc. (“Kallyope”), a biotechnology company focused on harnessing the potential of the gut-brain axis, today...
UPDATE 2-Merck KGaA, Threshold drug fails in late-stage cancer trials Pooja8 Dec 2015 10:52 AM ISTFRANKFURT, Dec 7 Germany's Merck KGaA and development partner Threshold Pharmaceuticals said their experimental cancer drug evofosfamide failed to...
Government caps price of 6 formulations packs Pooja13 Nov 2015 8:25 AM ISTNew Delhi: Government has capped prices of six drug formulations packs, including pain killer Ibuprofen, anti-infective Metronidazole, among...
US agencies investigate Merck, Lilly drug pricing Meghna A Singhania8 Nov 2015 11:25 AM ISTU.S. drugmakers Merck & Co and Eli Lilly & Co are being investigated by federal prosecutors over their drug-pricing practices, the companies...
Merck's Keytruda extends survival in lung cancer study Meghna A Singhania27 Oct 2015 11:14 AM ISTMerck & Co's approved Keytruda lung cancer treatment provided superior overall survival to chemotherapy in a late-stage study of patients with...
FDA expands Merck drug's approval to treat lung cancer Meghna A Singhania4 Oct 2015 12:35 PM ISTWASHINGTON: Federal health officials have expanded approval of an innovative Merck drug to treat patients with an advanced form of the most common...
Pfizer, Bristol revive cancer drugs that rev up immune system Meghna A Singhania8 Aug 2015 12:50 PM ISTSome of the most heralded new cancer drugs fight the disease by removing brakes on the immune system. Now a few leading drugmakers are paying...
SC notifies hiatus for Glenmark Pharmaceuticals-anti-diabetes drug -Prof.RamHarshSingh2 Jun 2015 1:43 PM ISTHolds institutional sales till July 22, allows selling existing stocks Glenmark Pharmaceuticals has been caught off-guard, in view of the brewing...
